Orange Book product · Brand (NDA)
LEXETTE
HALOBETASOL PROPIONATE
At a glance
May 24, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 24, 2018
8 yr 2 mo ago
Today
Patent 10857159 expires
Listed drug product patent expiration.
Nov 30, 2036
in 10 yr 7 mo
Patent 11020407 expires
Listed drug product patent expiration.
Nov 30, 2036
in 10 yr 7 mo
Patent 10857159*PED expires
Listed listed patent expiration.
May 30, 2037
in 11 yr 1 mo
Pharmaceutical detail
Active ingredient
HALOBETASOL PROPIONATE
Strength
0.05%
Dosage form
AEROSOL, FOAM
Route
TOPICAL
TE code
Not listed
Application
NDA 210566
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018BRYHALIBrand (NDA)
NDA 209355 · BAUSCH
- 2015ULTRAVATEBrand (NDA)
NDA 208183 · LACER PHARMA
- 1990ULTRAVATEBrand (NDA)
NDA 019967 · SUN PHARM INDS INC
- 1990ULTRAVATEBrand (NDA)
NDA 019968 · SUN PHARM INDS INC
- 2023HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 215266 · PADAGIS ISRAEL
- 2020HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 213560 · QUAGEN
- 2020HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 211464 · PADAGIS ISRAEL
- 2018HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 209978 · ENCUBE
- 2007HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 078162 · COSETTE PHARMS NC
- 2006HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077721 · COSETTE
- 2005HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077227 · SUN PHARMA CANADA
- 2005HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077109 · COSETTE PHARMS NC
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10857159 | Nov 30, 2036 | in 10 yr 7 mo | Product |
| 11020407 | Nov 30, 2036 | in 10 yr 7 mo | ProductU-3143 |
| 10857159*PED | May 30, 2037 | in 11 yr 1 mo |

